BLX‐1002 restores glucose sensitivity and enhances insulin secretion stimulated by GLP‐1 and sulfonylurea in type 2 diabetic pancreatic islets

BLX‐1002 is a novel thiazolidinedione with no peroxisome proliferator‐activated receptor (PPAR) activity that has been shown to improve glycemia in type 2 diabetes without weight gain. We previously found that BLX‐1002 selectively augments glucose‐sensitive (but not basal) insulin secretion in norma...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qimin, Zhang, Fan, Sjöholm, Åke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4098742/
https://www.ncbi.nlm.nih.gov/pubmed/24872354
http://dx.doi.org/10.14814/phy2.12014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4098742/
https://www.ncbi.nlm.nih.gov/pubmed/24872354
http://dx.doi.org/10.14814/phy2.12014

Ejemplares similares